CN102961429B - Traditional Chinese medicine formula for osteoproliferation - Google Patents
Traditional Chinese medicine formula for osteoproliferation Download PDFInfo
- Publication number
- CN102961429B CN102961429B CN201210558208.6A CN201210558208A CN102961429B CN 102961429 B CN102961429 B CN 102961429B CN 201210558208 A CN201210558208 A CN 201210558208A CN 102961429 B CN102961429 B CN 102961429B
- Authority
- CN
- China
- Prior art keywords
- hyperosteogeny
- chinese medicine
- traditional chinese
- osteoproliferation
- bone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese composition for osteoproliferation. The traditional Chinese composition comprises rhizoma cibotii, herba epimedii, eupolyphaga, black ants, loofah sponge and rhizoma drynariae. The herba epimedii is used for warming and invigorating kidney yang; the black ants and the rhizoma cibotii are used for nourishing the body; the rhizoma drynariae is used for straightening bones and is used as a monarch medicine; and the eupolyphaga and the loofah sponge are used as an assistant for promoting blood circulation to remove meridian obstruction; and after a patient is healed clinically, the osteoproliferation is not bounced; and a symptom is totally disappeared; and the existence of a fact that spurs are assimilated can be observed by an apparatus in an X-ray mode.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of Chinese medicine composition for the treatment of hyperosteogeny.
Background technology
Doctor trained in Western medicine is thought, hyperosteogeny is osseous tissue hypertrophy, is one of current cureless disease.Although hyperosteogeny is unlikely to want human life, patient must stand the sensation of various fiber crops pain for a long time, is make us very painful a kind of disease.
Clinical research, the practice of the traditional Chinese medical science show: hyperosteogeny, bony spur can be cured.
One, doctor trained in Western medicine thinks that hyperosteogeny can not be cured
Doctor trained in Western medicine is thought, bone matrix hyperplasia is a kind of normal physiological phenomenon, because with advancing age, the cartilage in joint is degenerated gradually, and the elasticity of cell reduces, osteoarthrosis is being worn unconsciously, the articular cartilage of the easy damaged such as neck, waist, knee joint, heel that especially activity is larger, is difficult to repair when not having blood vessel to supply nutrition, at this moment more vigorous in the peripheral blood recycle ratio of articular cartilage, just there will be compensatory cartilage to increase, this is the predecessor of hyperosteogeny.The cartilage of hypertrophy of long duration again by calcification, hyperosteogeny that Here it is.Bony spur, as asymptomatic, without the need to treatment, only occurs symptom, when being transformed into pathological state, just needs treatment.
Why does doctor trained in Western medicine say that hyperosteogeny can not be cured? doctor trained in Western medicine is thought, bone is perverse is exactly the hypertrophy of normal bone tissues part.
Doctor trained in Western medicine theory is thought: bony spur is the sclerotin of finger joint style edge hypertrophy, also known as hyperosteogeny, hyperosteogeny.Bony spur is mainly in spinal column and weight-bearing joints, is the physiological degeneration change in a joint.The factors such as its formation and the joint destabilization that age, articular trauma or regression cause, osteoarthrosis stress distribution are abnormal are relevant.It is a kind of normal physiological phenomenon, because with advancing age, the cartilage in joint is degenerated gradually, the elasticity of cell reduces, and osteoarthrosis is being worn unconsciously, the articular cartilage of the neck that especially activity is larger, waist, knee joint, heel equivalent damage, be difficult to repair when not having blood vessel to supply nutrition, at this moment more vigorous in the peripheral blood recycle ratio of articular cartilage, just there will be compensatory cartilage and increase, this is the predecessor of hyperosteogeny.The cartilage of hypertrophy of long duration again by calcification, hyperosteogeny that Here it is.
Two: TCM investigation thinks that hyperosteogeny can be cured
In the document of the traditional Chinese medical science, there is no the name of disease of " hyperosteogeny ", but from its pathology, the traditional Chinese medical science " rheumatism involving the bone " category can be belonged to.
The name of disease of existing " rheumatism involving the bone " in Huangdi's Internal Classics, points out that clinical for primary symptom, pathogenesis then has " the raw then marrow of kidney can not be expired " and the internal and external factor of " cold to " and causing with " unable to raise the limbs due to heaviness of the bones, aching pain in the bone marrow " for it.In " Huatuo's Zhongzang classic ", Jing-Yue Complete Works, " doctor's rock ", there is the etiology and pathogenesis that rheumatism involving the bone is relevant to discuss.The traditional Chinese medical science is thought " hyperosteogeny " with wound, and strain obstruction of collaterals by blood stasis, the damp that is affected by the cold, phlegm resistance, caused by liver and kidney deficiency etc. are relevant.
TCM, to the explaination of " rheumatism involving the bone " cause of disease, pathogenesis, is said in " Plain Questions inverse adjust opinion ": " be people person, plain kidney qi victory; take water as thing; sun weakness of QI, kidney fat is withered not long ... kidney person water also, and is born in bone; kidney not life; then marrow can not be expired, therefore cold even bone also, so can not shiver with severe cold person, name of disease says rheumatism involving the bone, is that people works as contracture of joint also." illustrating from the discussion of ancients: kidney qi weakness is the endogenous cause of ill that rheumatism involving the bone occurs.
Also say in " Plain Questions regulating menstruation opinion ": " cold solely to stay, then blood clotting tears, solidifying then arteries and veins is obstructed." highlighting weather transformation here, cold invasion is the condition causing " rheumatism involving the bone " symptom." cold-evil " extremely, then blood clotting is wept.
The period of the Song and Yuan Dynasties physician according to "Nei Jing" " blood must not closely it be empty, thus be arthralgia with cold limbs also " understanding, proposition " qi stagnation hemagglutination " is the key of rheumatism involving the bone pathogenesis, and has formulated the Coryza Treated by Syndrome Differentiation methods such as promoting blood circulation by removing wind, using medicines of both cold and hot natures simultaneously, invigorating spleen to remove dampness.
Qing Dynasty's doctor's Wang Qingren is thought: " that cures the disease wants; understanding QI and blood ", he clearly proposes the academic thesis of " numbness has blood stasis " in " under correction of the errors of medical works volume ", he says when " with activating blood and removing stasis Method " treats arthromyodynia: " total YIN nourishing; the heresy be subject to outward is attributed to where? always by wind and cold remuval of damp and hot; solidifying blood, more can not live.As water meets wind and cold, congeal into ice, ice becomes, and wind and cold is loose.This justice bright, is what difficult to control arthromyodynia? use Traditional Chinese medicine decoction for treating-ache and expelling atagnate.”
Medical science YE Tian shi, points out: " combined into numbness, so for years, exopathogen stays work to wet three gas of wind and cold, and QI and blood is all hindered, and it turns to and loses the stasis of blood and coagulate expectorant, and mixed place meridians, are stamped all in " Linzheng Zhinan Yi numbness ".If lose it to control, for many years weakness of QI, be extended down to discarded severe and lingering illness.”
More modern traditional Chinese medical science are thought: correct hyperosteogeny should be referred to as " bone coagulates ".
In sum, rheumatism involving the bone the cause of disease be: deficiency of kidney-QI, " cold-evil " extremely, then blood clotting tears.Hyperosteogeny is exactly the condensation of blood stasis.
Have correct in the cause of disease of hyperosteogeny, the understanding of pathogenesis, and the guidance of ancient medicine theory, the traditional Chinese medical science needs effective hyperosteogeny Chinese medicine composition in practice, to treat " rheumatism involving the bone " patient.
Therefore, prior art existing defects, needs further improvement and development.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition effectively can treating hyperosteogeny.
To achieve these goals, the present invention adopts following technical scheme:
Hyperosteogeny Chinese medicine composition, wherein, comprising: ripe Rhizoma Cibotii, Herba Epimedii, Eupolyphaga Seu Steleophaga, Formica fusca, Retinervus Luffae Fructus and Rhizoma Drynariae.
Described Chinese medicine composition, wherein, the weight proportion of each component is: ripe Rhizoma Cibotii 100g ~ 200g, Herba Epimedii 150g, Eupolyphaga Seu Steleophaga 100g ~ 300g, Formica fusca 200g, Retinervus Luffae Fructus 80g, Rhizoma Drynariae 100g ~ 300g.
Hyperosteogeny Chinese medicine composition provided by the invention, with Herba Epimedii warming and recuperating the kidney-YANG, Formica fusca, ripe Rhizoma Cibotii nourish the body, the strong skeleton of Rhizoma Drynariae, Eupolyphaga Seu Steleophaga, Retinervus Luffae Fructus promoting blood circulation to remove obstruction in the collateral, do not rebound after clinical cure, symptom disappears completely, and the fact observing the digested absorption of bony spur with instrument film making exists.
Detailed description of the invention
Below in conjunction with preferred embodiment, the present invention is described in further details.
Hyperosteogeny Chinese medicine composition of the present invention comprises: ripe Rhizoma Cibotii, Herba Epimedii, Eupolyphaga Seu Steleophaga, Formica fusca, Retinervus Luffae Fructus and Rhizoma Drynariae.
Preferably, in described hyperosteogeny Chinese medicine composition, the weight proportion of each component is: ripe Rhizoma Cibotii 100g ~ 200g, Herba Epimedii 150g, Eupolyphaga Seu Steleophaga 100g ~ 300g, Formica fusca 200g, Retinervus Luffae Fructus 80g, Rhizoma Drynariae 100g ~ 300g.
Hyperosteogeny Chinese medicine composition traditional method provided by the invention or modern crafts system, with the small honey pill of Chinese medicine and Mel 1:1.5, warm water delivery service, one day three times, one time 10 grams, by for oral administration, restorative health in the short time, the sclerotin of hypertrophy is absorbed by the body elimination, skeleton of getting well.
Hyperosteogeny Chinese medicine composition provided by the invention, with Herba Epimedii warming and recuperating the kidney-YANG, Formica fusca, ripe Rhizoma Cibotii nourish the body, the strong skeleton of Rhizoma Drynariae is monarch drug, Eupolyphaga Seu Steleophaga, Retinervus Luffae Fructus promoting blood circulation to remove obstruction in the collateral are auxiliary, do not rebound after clinical cure, symptom disappears completely, and the fact observing the digested absorption of bony spur with instrument film making exists.
Hyperosteogeny Chinese medicine composition of the present invention is thought in the treatment that " rheumatism involving the bone " is sick, and treatment " rheumatism involving the bone " is sick, medication focuses on the kidney warming sun, bone and muscle strengthening, hard masses softening and resolving, promoting blood circulation to remove obstruction in the collateral, blood stasis dispelling heresy be principle, can obtain desirable curative effect.
Above content is the explanation to preferred embodiment of the present invention, and those skilled in the art can be helped to understand technical scheme of the present invention more fully.But these embodiments only illustrate, can not assert that the specific embodiment of the present invention is only limitted to the explanation of these embodiments.Concerning general technical staff of the technical field of the invention, without departing from the inventive concept of the premise, some simple deductions and conversion can also be made, all should be considered as belonging to protection scope of the present invention.
Claims (1)
1. treat a Chinese medicine composition for hyperosteogeny, it is characterized in that: be made up of the crude drug of following weight proportioning: ripe Rhizoma Cibotii 100g ~ 200g, Herba Epimedii 150g, Eupolyphaga Seu Steleophaga 100g ~ 300g, Formica fusca 200g, Retinervus Luffae Fructus 80g, Rhizoma Drynariae 100g ~ 300g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210558208.6A CN102961429B (en) | 2012-12-20 | 2012-12-20 | Traditional Chinese medicine formula for osteoproliferation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210558208.6A CN102961429B (en) | 2012-12-20 | 2012-12-20 | Traditional Chinese medicine formula for osteoproliferation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102961429A CN102961429A (en) | 2013-03-13 |
| CN102961429B true CN102961429B (en) | 2015-05-13 |
Family
ID=47792048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210558208.6A Expired - Fee Related CN102961429B (en) | 2012-12-20 | 2012-12-20 | Traditional Chinese medicine formula for osteoproliferation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102961429B (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101940656A (en) * | 2010-08-13 | 2011-01-12 | 山西省屯留县科技情报服务中心 | Medicament for treating hyperosteogeny |
-
2012
- 2012-12-20 CN CN201210558208.6A patent/CN102961429B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102961429A (en) | 2013-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1118285C (en) | Shubi plaster for treating arthralgia due to wind-cold-dampness | |
| CN102641321B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc herniation and cervical hyperplasia and preparation method thereof | |
| CN103191274B (en) | Externally applied traditional Chinese medicine powder for treating lumbar disc herniation | |
| CN103933171B (en) | A kind of External apply medicinal wine for the treatment of lumbago and skelalgia | |
| CN103690711A (en) | Medicinal wine for dispersing pathogenic wind and activating collaterals | |
| Wu et al. | Needle-warming moxibustion plus multirehabilitation training to improve quality of life and functional mobility of patients with rheumatoid arthritis after medication | |
| CN103599400B (en) | Chinese medicinal plaster for the treatment of cervical spondylosis and preparation method thereof | |
| CN102526433A (en) | Medicine for treating articular contracture | |
| CN103393897B (en) | Externally used traditional Chinese medicine for treating hyperostosis and rheumatic ostealgia and preparation method thereof | |
| CN102961429B (en) | Traditional Chinese medicine formula for osteoproliferation | |
| CN104984313B (en) | A kind of Traditional Chinese medicinal liquor for treating pernio | |
| CN103585483B (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
| CN104173689B (en) | A kind of medicine for treating traumatic injury, protrusion of lumber intervertebral disc and scapulohumeral periarthritis and preparation method thereof | |
| CN103751446B (en) | A kind of Tibetan bee venom plaster treating osteopathia | |
| CN103705658B (en) | A kind of external traditional Chinese medicinal application for the treatment of rheumatoid arthritis | |
| CN1843441A (en) | Rheumatism-eliminating collaterals-dredging externally applied plaster | |
| CN104189102B (en) | A kind of Chinese medicine composition and preparation method thereof | |
| CN103920119B (en) | The external medicinal liquid for the treatment of closed bone injuries | |
| CN104706706A (en) | Hyperosteogeny traditional Chinese medicine formula | |
| Wu et al. | Fu's Subcutaneous Needling: A Novel Acupuncture Treatment for Musculoskeletal Pain Diseases. | |
| CN102258762B (en) | Medicinal composition for diminishing swelling and relieving pain and preparation and use thereof | |
| CN105434818A (en) | Traditional Chinese medicine preparation for treating cervical spondylosis | |
| CN102000235B (en) | Externally-applied health-care medicinal wine | |
| Wang | Therapeutic Effect of Chinese Massage Combined with Warm Acupuncture on Knee Osteoarthritis | |
| CN102178772A (en) | Mongolian medicament for strengthening muscles and bones, promoting blood circulation and removing blood stasis, diminishing inflammation and easing pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150513 Termination date: 20181220 |